Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leading-Gas is a clinical-stage biotechnology company based in Beijing that specializes in the development of gas-signal molecule (GSM) therapies. The company focuses on the therapeutic potential of medical gases such as carbon monoxide, hydrogen, and nitric oxide to treat inflammatory diseases and organ injuries. Their lead programs utilize proprietary delivery systems to provide controlled release of these gases for indications like delayed graft function in kidney transplants and acute kidney injury. By leveraging the physiological signaling properties of gases, Leading-Gas aims to provide innovative solutions for unmet needs in critical care and transplantation medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leading Gas.